South Korea
· Delayed Price · Currency is KRW ENBIO Statistics
Total Valuation
ENBIO has a market cap or net worth of KRW 24.24 billion. The enterprise value is 38.42 billion.
| Market Cap | 24.24B |
| Enterprise Value | 38.42B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ENBIO has 10.87 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Shares Outstanding | 10.87M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +37.04% |
| Owned by Insiders (%) | 35.69% |
| Owned by Institutions (%) | 4.95% |
| Float | 6.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| PB Ratio | 0.76 |
| P/FCF Ratio | 10.18 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.01 |
| EV / Sales | 1.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 16.13 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 39.37.
| Current Ratio | 1.94 |
| Quick Ratio | 0.12 |
| Debt / Equity | 39.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.25 |
| Interest Coverage | -1.13 |
Financial Efficiency
Return on equity (ROE) is -9.33% and return on invested capital (ROIC) is -2.65%.
| Return on Equity (ROE) | -9.33% |
| Return on Assets (ROA) | -2.12% |
| Return on Capital (ROIC) | -2.65% |
| Revenue Per Employee | 418.82M |
| Profits Per Employee | -53.27M |
| Employee Count | 80 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -50.72% |
| 50-Day Moving Average | 2,487.20 |
| 200-Day Moving Average | 2,997.25 |
| Relative Strength Index (RSI) | 32.78 |
| Average Volume (20 Days) | 23,679 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ENBIO had revenue of KRW 33.51 billion and -4.26 billion in losses. Loss per share was -391.48.
| Revenue | 33.51B |
| Gross Profit | 7.50B |
| Operating Income | -2.76B |
| Pretax Income | -5.39B |
| Net Income | -4.26B |
| EBITDA | -223.49M |
| EBIT | -2.76B |
| Loss Per Share | -391.48 |
Balance Sheet
The company has 3.07 billion in cash and 17.25 billion in debt, giving a net cash position of -14.18 billion or -1,304.79 per share.
| Cash & Cash Equivalents | 3.07B |
| Total Debt | 17.25B |
| Net Cash | -14.18B |
| Net Cash Per Share | -1,304.79 |
| Equity (Book Value) | 43.83B |
| Book Value Per Share | 2,942.81 |
| Working Capital | 23.42B |
Cash Flow
In the last 12 months, operating cash flow was 9.18 billion and capital expenditures -6.80 billion, giving a free cash flow of 2.38 billion.
| Operating Cash Flow | 9.18B |
| Capital Expenditures | -6.80B |
| Free Cash Flow | 2.38B |
| FCF Per Share | 219.10 |
Margins
Gross margin is 22.37%, with operating and profit margins of -8.22% and -12.72%.
| Gross Margin | 22.37% |
| Operating Margin | -8.22% |
| Pretax Margin | -16.08% |
| Profit Margin | -12.72% |
| EBITDA Margin | -0.67% |
| EBIT Margin | -8.22% |
| FCF Margin | 7.11% |
Dividends & Yields
ENBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | -0.29% |
| Earnings Yield | -17.56% |
| FCF Yield | 9.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |